Numerical modeling of thermal dust polarization from aligned grains in the envelope of evolved stars with updated POLARIS

Magnetic fields are thought to influence the formation and evolution of evolved star envelopes. Thermal dust polarization from magnetically aligned grains is potentially a powerful tool for probing magnetic fields and dust properties in these circumstellar environments. In this paper, we present numerical modeling of thermal dust polarization from the envelope of IK Tau using the magnetically enhanced radiative torque (MRAT) alignment theory implemented in our updated POLARIS code. Due to the strong stellar radiation field, the minimum size required for RAT alignment of silicate grains is $\sim 0.005 - 0.05\,\rm\mu m$. Additionally, ordinary paramagnetic grains can achieve perfect alignment by MRAT in the inner regions of $r < 500\,\rm au$ due to stronger magnetic fields of $B\sim 10$ mG - 1G, producing thermal dust polarization degree of $\sim 10\,\%$. The polarization degree can be enhanced to $\sim 20-40\%$ for grains with embedded iron inclusions. We also find that the magnetic field geometry affects the alignment size and the resulting polarization degree due to the projection effect in the plane-of-sky. We also study the spectrum of polarized thermal dust emission and find the increased polarization degree toward $\lambda > 50\,\rm\mu m$ due to the alignment of small grains by MRAT. Furthermore, we investigate the impact of rotational disruption by RATs (RAT-D) and find the RAT-D effect cause a decrease in the dust polarization fraction. Finally, we compare our numerical results with available polarization data observed by SOFIA/HAWC+ for constraining dust properties, suggesting grains are unlikely to have embedded iron clusters and might have slightly elongated shapes. Our modeling results suggest further observational studies at far-infrared/sub-millimeter wavelengths to understand the properties of magnetic fields and dust in AGB envelopes.Comment: 27 pages, 23 figures, 1 table, to be submitte

Studying Magnetic Fields and Dust in M17 Using Polarized Thermal Dust Emission Observed by SOFIA/HAWC

We report on the highest spatial resolution measurement to date of magnetic fields (B-fields) in M17 using thermal dust polarization measurements taken by SOFIA/HAWC+ centered at a wavelength of 154 μm. Using the Davis–Chandrasekhar–Fermi method, in which the polarization angle dispersion calculated using the structure function technique is the quantity directly observed by SOFIA/HAWC+, we found the presence of strong B-fields of 980 ± 230 and 1665 ± 885 μG in the lower-density M17-N and higher-density M17-S regions, respectively. The B-field morphology in M17-N possibly mimics the fields in gravitationally collapsing molecular cores, while in M17-S the fields run perpendicular to the density structure. M17-S also displays a pillar feature and an asymmetric large-scale hourglass-shaped field. We use the mean B-field strengths to determine Alfvénic Mach numbers for both regions, finding that B-fields dominate over turbulence. We calculate the mass-to-flux ratio, λ, finding λ = 0.07 for M17-N and 0.28 for M17-S. These subcritical λ values are consistent with the lack of massive stars formed in M17. To study dust physics, we analyze the relationship between dust polarization fraction, p, emission intensity, I, gas column density, N(H2), polarization angle dispersion function, S, and dust temperature, T d. p decreases with intensity as I −α with α = 0.51. p tends to first increase with T d, but then decreases at higher T d. The latter feature, seen in M17-N at high T d when N(H2) and S decrease, is evidence of the radiative torque disruption effect

ANTIMICROBIAL COMPOUNDS FROM RHIZOPHORA STYLOSA

(6S,7E,9R)-6,9-dihydroxy-4,7-megastiymadien-3-one 9-O-[α-L-arabinopyranosyl-(l→6)-β-D-glucopyranoside] (1), blumenol A (2), and kaempferol 3-rutinoside (3) were isolated from the methanol extract of the leaves of mangrove plant Rhizophora stylosa Griff. Structural elucidation of the metabolites was carried out by analysis of their spectroscopic data and by comparison with those reported in the literature. All these compounds exhibited antimicrobial activity and were isolated from this genus for the first time

Five lignans from the mangrove Rhizophora stylosa Griff.

Five lignans (-)-(7R,8S)-dihydrodehydrodiconiferyl alcohol (1), (7S,8R)-3,3¢,5-trimethoxy-4¢,7-epoxy-8,5¢-neolignan-4,9,9¢-triol (2), (+)-isolariciresinol (3), polystachyol (4), (+)-pinoresinol (5) were isolated from the mangrove plant Rhizophora stylosa Griff.. The chemical structures of these compounds were elucidated by analysis of their NMR spectra and compared with those reported references. All these compounds were isolated from this plant for the first time

GLUCOSIDES AND UREA DERIVATIVES FROM THE SEEDS OF SCAPHIUM MACROPODUM (MIQ.) BEUMÉE

Five known compounds {carbonylbis[imino(6-methyl-3,1-phenylenel)]}bis[carbamic acid] dimethyl ester (1), (1'R,3'S,5'R,8'S,2E,4E-dihydrophaseic acid) 3'-O-beta-D-glucopyranoside (2), 3-methylbutan-1-ol beta-D-glucopyranoside (3), astragalin (4) and daucosterol (5) were isolated from the methanol extract of the seeds of Scaphium macropodum (Miq.) Beumée. The structures of the isolated compounds were elucidated by the spectroscopic methods including NMR and MS, and also by comparison with the literature data. Compounds 1-3 were isolated from this plant for the first time

A polyhydroxylated sterol and a saponin isolated from the starfish culcita novaeguineae

Using various chromatographic methods, a polyhydroxylated sterol 5α-cholestane-3β,6β,7α,8β,15α,16β,26-heptol (1) and an asterosaponin sodium salt of 6α-[(O-β-D-fucopyranosyl-(l®2)-O-β-D-galactopyranosyl-(l®4)-O-[β-D-quinovopyranosyl-(l®2)]-O-β-D-xylopyranosyl-(l®3)-O-β-D-quinovopyranosyl)oxy]-5α-pregn-9(11)-ene-20-one (2), were isolated from the methanol extract of the starfish Culcita novaeguineae. Their structures were elucidated by 1D and 2D-NMR experiments and comparison of their NMR data with reported values. Compounds 1 was isolated from         C. novaeguineae for the first time

A Multi-Center Randomised Controlled Trial of Gatifloxacin versus Azithromycin for the Treatment of Uncomplicated Typhoid Fever in Children and Adults in Vietnam

BACKGROUND: Drug resistant typhoid fever is a major clinical problem globally. Many of the first line antibiotics, including the older generation fluoroquinolones, ciprofloxacin and ofloxacin, are failing. OBJECTIVES: We performed a randomised controlled trial to compare the efficacy and safety of gatifloxacin (10 mg/kg/day) versus azithromycin (20 mg/kg/day) as a once daily oral dose for 7 days for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. METHODS: An open-label multi-centre randomised trial with pre-specified per protocol analysis and intention to treat analysis was conducted. The primary outcome was fever clearance time, the secondary outcome was overall treatment failure (clinical or microbiological failure, development of typhoid fever-related complications, relapse or faecal carriage of S. typhi). PRINCIPAL FINDINGS: We enrolled 358 children and adults with suspected typhoid fever. There was no death in the study. 287 patients had blood culture confirmed typhoid fever, 145 patients received gatifloxacin and 142 patients received azithromycin. The median FCT was 106 hours in both treatment arms (95% Confidence Interval [CI]; 94-118 hours for gatifloxacin versus 88-112 hours for azithromycin), (logrank test p = 0.984, HR [95% CI] = 1.0 [0.80-1.26]). Overall treatment failure occurred in 13/145 (9%) patients in the gatifloxacin group and 13/140 (9.3%) patients in the azithromycin group, (logrank test p = 0.854, HR [95% CI] = 0.93 [0.43-2.0]). 96% (254/263) of the Salmonella enterica serovar Typhi isolates were resistant to nalidixic acid and 58% (153/263) were multidrug resistant. CONCLUSIONS: Both antibiotics showed an excellent efficacy and safety profile. Both gatifloxacin and azithromycin can be recommended for the treatment of typhoid fever particularly in regions with high rates of multidrug and nalidixic acid resistance. The cost of a 7-day treatment course of gatifloxacin is approximately one third of the cost of azithromycin in Vietnam. TRIAL REGISTRATION: Controlled-Trials.com ISRCTN67946944

In Vitro Antibiotic Resistance in Bacterial Infected Eczema at Ho Chi Minh City Hospital of Dermatology

BACKGROUND: Infected eczema is one of the most common complications of eczema. The progression and treatment of infected eczema have become more complex and difficulty due to the antibiotic resistance of bacteria and the abuse of antibiotics in treatment. AIM: Our research was conducted with the aim of investigating the severity of in vitro antibiotic resistance in patients with bacterially infected eczema at Ho Chi Minh City Hospital of Dermatology. METHODS: We studied 40 cases of patients, suffering from atopic dermatitis, contact dermatitis, vesicular palmoplantar eczema, with positive results of infected eczema. RESULTS: S. aureus accounted for 82.5%, followed by S. epidermidis (15%), P. aeruginosa (12.5%), S. pyogenes (5%) accounted for a small percentage. E. coli (2.5%) and M. morganii (2.5%) accounted for the lowest percentage. Both MSSA and MRSA were completely resistant to penicillin. MRSA is completely resistant to penicillin, erythromycin, and cefuroxime, highly resistant to clindamycin (82.35%). Our research showed that Pseudomonas aeruginosa was not resistant to a variety of antibiotics. It was completely resistant to tetracycline, trimethoprim/sulfamethoxazole (100%). Most bacteria are highly sensitive to linezolid, vancomycin as other studies in the world shown. There are also rifampicins, pristinamycin. Hence, it`s prioritised to be used for only patients with eczema infected with multidrug-resistant bacteria. CONCLUSION: Penicillin is not recommended for the treatment for infected eczema. Linezolid, vancomycin has a high sensitivity to bacteria including multidrug-resistant bacteria like MRSA

The influence of human genetic variation on early transcriptional responses and protective immunity following immunization with Rotarix vaccine in infants in Ho Chi Minh City in Vietnam : a study protocol for an open single-arm interventional trial [awaiting peer review]

Background: Rotavirus (RoV) remains the leading cause of acute gastroenteritis in infants and children aged under five years in both high- and low-middle-income countries (LMICs). In LMICs, RoV infections are associated with substantial mortality. Two RoV vaccines (Rotarix and Rotateq) are widely available for use in infants, both of which have been shown to be highly efficacious in Europe and North America. However, for unknown reasons, these RoV vaccines have markedly lower efficacy in LMICs. We hypothesize that poor RoV vaccine efficacy across in certain regions may be associated with genetic heritability or gene expression in the human host. Methods/design: We designed an open-label single-arm interventional trial with the Rotarix RoV vaccine to identify genetic and transcriptomic markers associated with generating a protective immune response against RoV. Overall, 1,000 infants will be recruited prior to Expanded Program on Immunization (EPI) vaccinations at two months of age and vaccinated with oral Rotarix vaccine at two and three months, after which the infants will be followed-up for diarrheal disease until 18 months of age. Blood sampling for genetics, transcriptomics, and immunological analysis will be conducted before each Rotarix vaccination, 2-3 days post-vaccination, and at each follow-up visit (i.e. 6, 12 and 18 months of age). Stool samples will be collected during each diarrheal episode to identify RoV infection. The primary outcome will be Rotarix vaccine failure events (i.e. symptomatic RoV infection despite vaccination), secondary outcomes will be antibody responses and genotypic characterization of the infection virus in Rotarix failure events. Discussion: This study will be the largest and best powered study of its kind to be conducted to date in infants, and will be critical for our understanding of RoV immunity, human genetics in the Vietnam population, and mechanisms determining RoV vaccine-mediated protection. Registration: ClinicalTrials.gov, ID: NCT03587389. Registered on 16 July 2018

Enhancing Sesquiterpenoid Production from Methane via Synergy of the Methylerythritol Phosphate Pathway and a Short-Cut Route to 1-Deoxy-D-xylulose 5-Phosphate in Methanotrophic Bacteria

Sesquiterpenoids are one of the most diverse classes of isoprenoids which exhibit numerous potentials in industrial biotechnology. The methanotrophs-based methane bioconversion is a promising approach for sustainable production of chemicals and fuels from methane. With intrinsic high carbon flux though the ribulose monophosphate cycle in Methylotuvimicrobium alcaliphilum 20Z, we demonstrated here that employing a short-cut route from ribulose 5-phosphate to 1-deoxy-d-xylulose 5-phosphate (DXP) could enable a more efficient isoprenoid production via the methylerythritol 4-phosphate (MEP) pathway, using α-humulene as a model compound. An additional 2.8-fold increase in α-humulene production yield was achieved by the fusion of the nDXP enzyme and DXP reductase. Additionally, we utilized these engineering strategies for the production of another sesquiterpenoid, α-bisabolene. The synergy of the nDXP and MEP pathways improved the α-bisabolene titer up to 12.24 ± 0.43 mg/gDCW, twofold greater than that of the initial strain. This study expanded the suite of sesquiterpenoids that can be produced from methane and demonstrated the synergistic uses of the nDXP and MEP pathways for improving sesquiterpenoid production in methanotrophic bacteria